Oral Oncology
Volume 45, Issue 12 , Pages 1006-1010 , December 2009

Saliva as a tool for oral cancer diagnosis and prognosis

Received 17 April 2009 ,Revised 6 July 2009 ,Accepted 6 July 2009.

References 

  1. Pickering V, Jordan RC, Schmidt BL. Elevated salivary endothelin levels in oral cancer patients – a pilot study. Oral Oncol. 2007;43:37–41
  2. Saracoglu U, Guven O, Durak I. Adenosine deaminase and 5′-nucleotidase activities in saliva from patients with oral and laryngeal cancer. Oral Dis. 2005;11:323–325
  3. Zhong LP, Chen GF, Xu ZF, Zhang X, Ping FY, Zhao SF. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg. 2005;34:566–570
  4. Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:735–739
  5. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev. 2005;29:42–45
  6. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol. 2005;114:278–283
  7. St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:929–935
  8. Kim MM, Clinger JD, Masayesva BG, Ha PK, Zahurak ML, Westra WH, et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res. 2004;10:8512–8515
  9. Dowling P, Wormald R, Meleady P, Henry M, Curran A, Clynes M. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteomics. 2008;71:168–175
  10. Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, Spyridonidou S, et al. Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2008;134:821–832
  11. Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1348–1355
  12. Zhong LP, Zhang CP, Zheng JW, Li J, Chen WT, Zhang ZY. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients. Arch Oral Biol. 2007;52:1079–1087
  13. Viet CT, Schmidt BL. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev. 2008;17:3603–3611
  14. Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res. 2008;14:97–107
  15. Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res. 2007;13:1179–1185
  16. Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho OP, et al. Prognostic factors in tongue cancer – relative importance of demographic, clinical and histopathological factors. Br J Cancer. 2000;83:614–619
  17. Myers JN, Elkins T, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg. 2000;122:44–51
  18. Alho OP, Kantola S, Pirkola U, Laara E, Jokinen K, Pukkala E. Cancer of the mobile tongue in Finland – increasing incidence, but improved survival. Acta Oncol. 1999;38:1021–1024
  19. Esser D, Anke S, Roessner A, Freigang B. Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings. Laryngorhinootologie. 2000;79:478–482
  20. Nagler RM, Braun J, Daitzman M, Laufer D. Spiral CT angiography – an alternative vascular evaluation technique for head and neck microvascular reconstruction: a preliminary experience. Plast Reconst Surg. 1997;100:1697–1703
  21. Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck. 2004;26:984–994
  22. Yeole BB, Sankaranarayanan R, Sunny ML, Swaminathan R, Parkin DM. Survival from head and neck cancer in Mumbai (Bombay), India. Cancer. 2000;89:437–444
  23. Ribeiro KC, Kowalski LP, Latorre MR. Impact of comorbidity, symptoms, and patients’ characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg. 2000;126:1079–1085
  24. Sparano A, Weinstein G, Chalian A, Yodul M, Weber R. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg. 2004;131:472–476
  25. Yuen PW, Lam KY, Chan AC, Wei WI, Lam LK. Clinicopathological analysis of local spread of carcinoma of the tongue. Am J Surg. 1998;175:242–244
  26. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer. 1995;75:147–153
  27. Nagler RM, Barak M, Ben-Aryeh H, Peled M, Filatov M, Laufer D. Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer. 1999;35:1018–1025
  28. Bhatavdekar JM, Patel DD, Vora HH, Balar DB. Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol. 1993;14:55–58
  29. Bhatavdekar JM, Patel DD, Vora HH, Balar DB. Circulating prolactin and TPS in monitoring the clinical course of male patients with metastatic tongue cancer: a preliminary study. Anticancer Res. 1993;13:237–240
  30. Yen TC, Lin WY, Kao CH, Cheng KY, Wang SJ. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol. 1998;23:82–86
  31. Hellner D, Klapdor R, Gundlach KH, Schmelze R. Results with the use of the Scc antigen in squamous cell carcinomas of the oral cavity. Dtsch Z Mund Kiefer Gesichtschir. 1989;13:291–295
  32. Zoller J, Fiehn W, Mende U, Hotz G. The diagnostic value of the tumor markers CEA, “Ca 19-9”, “Ca 125”, “Ca15-3” and “SCC” for the detection of recurrent tumors in patients with tumors of the head and neck. Dtsch Z Mund Kiefer Gesichtschir. 1990;14:254–259
  33. Zoller J. The value of “tumor markers” in the therapy and aftercare of carcinoma of the oral mucosa. Dtsch Zahn Mund Kieferheilkd Zentralbl. 1992;80:351–357
  34. Kuo WR, Lee KW, Ho KY, Tsai SM, Chiang FY, Juan KH. Tissue polypeptide antigen, carcinoembryonic antigen, carbohydrate antigen, and CA125 levels as tumor markers in squamous cell carcinoma of the head and neck. Kaohsiung J Med Sci. 1999;15:152–158
  35. Krimmel M, Hoffmann J, Krimmel C, Cornelius CP, Schwenzer N. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer. J Craniomaxillofac Surg. 1998;26:243–248
  36. Hoffmann J, Munz A, Krimmel M, Alfter G. Intraoperative and postoperative kinetics of serum tumor markers in patients with oral carcinoma. J Oral Maxillofac Surg. 1998;56:1390–1393
  37. Kurokawa H, Tsuru S, Okada M, Nakamura T, Kajiyama M. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg. 1993;22:35–38
  38. Kurokawa H, Yamashita Y, Tokudome S, Kajiyama M. Combination assay for tumor markers in oral squamous cell carcinoma. J Oral Maxillofac Surg. 1997;55:964–966
  39. Bigler LR, Streckfus CF, Copeland L, Burns R, Dai X, Kuhn M, et al. The potential use of saliva to detect recurrence of disease in women with breast carcinoma. J Oral Pathol Med. 2002;31:421–431
  40. Negri L, Pacchioni D, Calabrese F, Giacomasso S, Mastromatteo V, Fazio M. Serum and salivary CEA and GICA levels in oral cavity tumours. Int J Biol Markers. 1988;3:107–112
  41. Airoldi M, Negri L, Pedani F, Gerbino G, Camoletto D, Piantino P. Serum and salivary CEA in benign and malignant lesions of the oral cavity. Boll Soc Ital Biol Sper. 1984;60:865–870
  42. Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers – a new diagnostic tool for oral cancer. Clin Cancer Res. 2006;12:3979–3984
  43. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM. Salivary analysis in oral cancer patients – DNA and protein oxidation, reactive nitrogen species and antioxidant profile. Cancer. 2007;109:54–59
  44. Almadori G, Bussu F, Galli J, Limongelli A, Persichilli S, Zappacosta B, et al. Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma. Head Neck. 2007;29:648–654
  45. Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. Cancer Res Clin Oncol. 2007;133:613–617
  46. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn. 2001;3:164–170
  47. Lea IA, Jackson MA, Li X, Bailey S, Peddada SD, Dunnick JK. Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis. 2007;28:1851–1858
  48. Zhang L, Rosin MP. Loss of heterozygosity: a potential tool in management of oral premalignant lesions?. J Oral Pathol Med. 2001;30:513–520
  49. Viet CT, Jordan RC, Schmidt BL. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dent Assoc. 2007;35:844–849
  50. Righini CA, de Fraipont F, Reyt E, Favrot MC. Aberrant methylation of tumor suppressor genes in head and neck squamous cell carcinoma: is it clinically relevant?. Bull Cancer. 2007;94:191–197
  51. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001;61:939–942
  52. Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H, Chia D, et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008;14:705–712
  53. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008;14:6246–6252
  54. Tan W, Sabet L, Li Y, Yu T, Klokkevold PR, Wong DT, et al. Optical protein sensor for detecting cancer markers in saliva. Biosens Bioelectron. 2008;24:266–271
  55. Zimmermann BG, Wong DT. Salivary mRNA targets for cancer diagnostics. Oral Oncol. 2008;44:425–429
  56. Hu S, Yen Y, Ann D, Wong DT. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery. Drug Discov Today. 2007;12:911–916
  57. Hu S, Yu T, Xie Y, Yang Y, Li Y, Zhou X, et al. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genom Proteom. 2007;4:55–64
  58. Hu S, Loo JA, Wong DT. Human saliva proteome analysis. Ann NY Acad Sci. 2007;1098:323–329
  59. Zimmermann BG, Park NJ, Wong DT. Genomic targets in saliva. Ann NY Acad Sci. 2007;1098:184–191
  60. Park NJ, Zhou X, Yu T, Brinkman BM, Zimmermann BG, Palanisamy V, et al. Characterization of salivary RNA by cDNA library analysis. Arch Oral Biol. 2007;52:30–35
  61. Wong DT. Salivary diagnostics for oral cancer. J Calif Dent Assoc. 2006;34:303–308
  62. Wong DT. Towards a simple, saliva-based test for the detection of oral cancer ‘oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance’. Expert Rev Mol Diagn. 2006;6:267–272
  63. Park NJ, Li Y, Yu T, Brinkman BM, Wong DT. Characterization of RNA in saliva. Clin Chem. 2006;52:988–994
  64. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc. 2006;137:313–321
  65. Brinkman BM, Wong DT. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol. 2006;18:228–233
  66. Yang CY, Brooks E, Li Y, Denny P, Ho CM, Qi F, et al. Detection of picomolar levels of interleukin-8 in human saliva by SPR. Lab Chip. 2005;5:1017–1023
  67. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004;10:8442–8450

PII: S1368-8375(09)00849-5

doi: 10.1016/j.oraloncology.2009.07.005

Oral Oncology
Volume 45, Issue 12 , Pages 1006-1010 , December 2009

Article Tools